Retirement Group’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Retirement Group’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-250	Closed	-$10K	–	741
2021 Q4	$10K	Hold	250	–	–	﹤0.01%	430
2021 Q3	$11K	Hold	250	–	–	0.01%	369
2021 Q2	$12K	Hold	250	–	–	0.01%	382
2021 Q1	$13K	Hold	250	–	–	0.01%	442
2020 Q4	$12K	Hold	250	–	–	0.01%	411
2020 Q3	$10K	Hold	250	–	–	0.01%	409
2020 Q2	$11K	Buy	+250	New	+$9.57K	0.01%	377
2019 Q4	$10K	Buy	+250	New	+$7.44K	0.01%	380

Other funds holding BBC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Retirement Group's BBC Position: Q1 2022 in Review

Retirement Group sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2022, closing a stake of 250 shares — an estimated $10K sold.

Retirement Group first reported a position in BBC in Q4 2019 and held it in 8 quarters. The position peaked at $13K in Q1 2021. 18 funds tracked by Wall St. Rank hold BBC as of Q1 2022.

Retirement Group reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2022 after selling out during the quarter.
Retirement Group sold 250 Virtus Biotech Clinical Trials ETF shares in Q1 2022, an estimated $10K.
Retirement Group first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2019 and held it in 8 quarters.
Retirement Group's Virtus Biotech Clinical Trials ETF position peaked at $13K in Q1 2021.
18 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2022.

Based on Retirement Group's 13F filing for Q1 2022, filed 6 May 2022.